Overview A Study of BION-1301 in Adults With IgA Nephropathy Status: Not yet recruiting Trial end date: 2028-05-01 Target enrollment: Participant gender: Summary Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy Phase: Phase 3 Details Lead Sponsor: Chinook Therapeutics, Inc.